Gestational diabetes mellitus (GDM) is one of the most common medical conditions that can arise during pregnancy, affecting approximately 6% to 9% of pregnancies in the United States. Because GDM often presents with no obvious symptoms, routine screening is essential for early detection and management. The timing of that screening can significantly influence the accuracy of results and the effectiveness of subsequent care. Knowing when to schedule your GDM screening test — and understanding why that timing matters — empowers you to make informed decisions with your healthcare provider.

Understanding Gestational Diabetes Mellitus

Gestational diabetes is a temporary form of diabetes that develops only during pregnancy. It occurs when the body cannot produce enough insulin to overcome the natural increase in insulin resistance caused by placental hormones, particularly human placental lactogen and growth hormone. As pregnancy progresses, these hormones make it more difficult for cells to use glucose, leading to elevated blood sugar levels.

While GDM usually resolves after delivery, it poses immediate risks to both mother and baby if left unmanaged. For the mother, untreated GDM increases the likelihood of preeclampsia, cesarean delivery, and the development of type 2 diabetes later in life. For the baby, high maternal blood glucose can cause excessive growth (macrosomia), neonatal hypoglycemia, jaundice, and respiratory distress syndrome. Long-term, children born to mothers with GDM have a higher risk of obesity and metabolic disorders.

Because these risks can be significantly reduced with proper monitoring and treatment, universal screening for GDM is recommended by major health organizations, including the American College of Obstetricians and Gynecologists (ACOG) and the U.S. Preventive Services Task Force.

The Standard Screening Window: 24 to 28 Weeks

For most pregnant women, the recommended time for GDM screening is between the 24th and 28th week of pregnancy. This window is not arbitrary; it aligns with the natural progression of insulin resistance. At around 24 weeks, placental hormone levels have risen sufficiently to challenge glucose metabolism, making abnormalities easier to detect.

Testing too early (before 24 weeks) may miss cases of GDM that develop later in the second trimester, leading to a false sense of security. Conversely, waiting beyond 28 weeks delays diagnosis and intervention, potentially allowing hyperglycemia to affect fetal development and maternal health over the final trimester. The 24- to 28-week window represents the optimal balance between sensitivity and practicality.

One-Step vs. Two-Step Screening Protocols

Two main protocols are used for GDM screening, and your provider’s choice may influence exactly when within that 4-week window you are tested.

  • Two-step approach: The first step is a 50-gram glucose challenge test (GCT), which does not require fasting. If the one-hour blood glucose level exceeds a certain threshold (typically 130-140 mg/dL), a second diagnostic step is performed: a 100-gram, three-hour oral glucose tolerance test (OGTT) after fasting overnight. The two-step approach is more common in North America.
  • One-step approach: This involves a 75-gram, two-hour OGTT performed after an overnight fast. Diagnosis is made based on one or more elevated values from the fasting, one-hour, or two-hour blood draws. This method is recommended by the International Association of Diabetes and Pregnancy Study Groups and is widely used outside the United States.

Both approaches are effective when administered during the 24- to 28-week window. Your provider will discuss which protocol they use and whether you need any special preparation.

When to Consider Earlier Screening (First Trimester or Early Second Trimester)

Some women have risk factors that make them more likely to develop GDM earlier in pregnancy or to have pre-existing undiagnosed type 2 diabetes. For these individuals, waiting until 24 weeks may delay necessary care. Early screening is typically recommended for women with any of the following risk factors:

  • Body mass index (BMI) of 30 or higher before pregnancy
  • Previous history of GDM or a prior large-for-gestational-age infant (over 9 pounds)
  • Family history of type 2 diabetes in a first-degree relative
  • Polycystic ovary syndrome (PCOS) or other conditions associated with insulin resistance
  • Maternal age 35 years or older
  • History of glucosuria (glucose in urine) in early pregnancy
  • Ethnic background with a higher prevalence of diabetes, such as Hispanic, African American, Native American, South Asian, or Pacific Islander descent

If you have one or more of these risk factors, your healthcare provider may order a fasting blood glucose test or an A1C measurement at your first prenatal visit. Some guidelines, such as those from ACOG, acknowledge that early screening in high-risk women can identify overt diabetes (type 2) or early GDM. If the initial test is normal, repeat testing is still recommended at 24-28 weeks because GDM may develop later in pregnancy.

What Early Screening Involves

Early screening is usually simpler than the full OGTT. A fasting plasma glucose test or a hemoglobin A1C test can be performed quickly at any stage of pregnancy. If results are abnormal, your provider will likely proceed with a diagnostic OGTT to confirm. Managing hyperglycemia from the first trimester can help reduce the risk of congenital anomalies and early pregnancy complications linked to uncontrolled diabetes.

When Later Screening May Be Needed (Beyond 28 Weeks)

Ideally, every pregnant patient completes GDM screening by 28 weeks. However, circumstances sometimes cause a delay. If you miss the 24- to 28-week window — for example, because of late initiation of prenatal care or scheduling conflicts — testing can still be performed in the third trimester. Although less than ideal, late screening is better than no screening at all. Providers may also recommend repeat testing after 28 weeks if you develop new symptoms suggestive of GDM, such as excessive thirst, frequent urination, or recurrent infections.

In some cases, a woman who had a normal test at 24-28 weeks may later exhibit signs of excessive fetal growth (detected on ultrasound) or elevated blood glucose on routine urine dipstick. Under these circumstances, repeat screening or a full OGTT may be ordered even if the earlier results were normal. Always discuss any changes in your health with your provider.

What to Expect During GDM Screening

Knowing the steps involved can reduce anxiety and help you prepare.

The Glucose Challenge Test (GCT)

For the two-step protocol, the initial GCT is non-fasting. You will drink a sweet beverage containing 50 grams of glucose. One hour later, a blood sample is drawn to measure your blood sugar level. You can eat normally before the test, though some clinicians recommend avoiding high-sugar meals on the morning of the test. If your result is above the cutoff (usually 130-140 mg/dL), you will need to return for the three-hour OGTT.

The Oral Glucose Tolerance Test (OGTT)

Whether as the second step or as a one-step diagnostic, the OGTT requires fasting for 8-14 hours (typically overnight). After a fasting blood draw, you drink a glucose solution (either 75 or 100 grams). Blood samples are then taken at intervals over the next two or three hours. During this time, you must remain seated and avoid eating or drinking anything except water. The test can be time-consuming but is essential for an accurate diagnosis.

Interpreting Your Results

Thresholds vary slightly depending on the protocol and the guidelines your provider follows. For the one-step 75-gram OGTT, the diagnosis of GDM is made if at least one of the following values is met or exceeded:

  • Fasting: 92 mg/dL (5.1 mmol/L)
  • 1-hour: 180 mg/dL (10.0 mmol/L)
  • 2-hour: 153 mg/dL (8.5 mmol/L)

For the two-step 100-gram OGTT, the Carpenter-Coustan criteria are commonly used, requiring at least two elevated values out of four:

  • Fasting: 95 mg/dL (5.3 mmol/L)
  • 1-hour: 180 mg/dL (10.0 mmol/L)
  • 2-hour: 155 mg/dL (8.6 mmol/L)
  • 3-hour: 140 mg/dL (7.8 mmol/L)

A borderline result — sometimes called impaired glucose tolerance — may lead to recommendations for dietary modifications and closer monitoring, even if a full GDM diagnosis is not made. Your provider will explain what your numbers mean for your pregnancy.

Why Accurate Timing Matters for Reliable Results

Scheduling the GDM test too early in pregnancy can produce a false-negative result because insulin resistance has not yet peaked. A woman who tests normal at 16 weeks might still develop GDM by 28 weeks. Conversely, testing too late can allow weeks of unmanaged hyperglycemia to affect fetal growth and increase the mother’s risk of hypertensive disorders. The 24- to 28-week window minimizes both of these problems.

Research shows that women diagnosed with GDM between 24 and 28 weeks who receive timely intervention (dietary counseling, blood glucose monitoring, and medication if needed) have outcomes similar to those without GDM — a powerful testament to the value of proper timing. Delayed diagnosis, by contrast, is associated with higher rates of macrosomia, shoulder dystocia, neonatal hypoglycemia, and maternal cesarean delivery.

For a more detailed review of the evidence, the Centers for Disease Control and Prevention provides an excellent overview of gestational diabetes. Additionally, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) offers comprehensive diagnosis guidelines for GDM.

Managing GDM After Diagnosis

If you receive a GDM diagnosis, do not panic. With proper management, most women with GDM have healthy pregnancies and babies. The cornerstone of treatment includes:

  • Blood glucose monitoring: Checking your blood sugar levels at home, usually upon waking and after meals, to track patterns.
  • Dietary modifications: Working with a dietitian to balance carbohydrates, protein, and fats; learning to count carbohydrates and choose low glycemic foods.
  • Physical activity: Moderate exercise such as walking for 30 minutes most days can improve insulin sensitivity.
  • Medication if needed: Some women require insulin or oral medications like metformin to achieve target glucose levels. This is safe and effective during pregnancy.
  • Fetal monitoring: Extra ultrasound exams to check fetal growth and amniotic fluid volume, and potentially non-stress tests in the third trimester.

Early detection through well-timed screening allows these interventions to begin before significant harm occurs. ACOG’s patient education page on gestational diabetes is a reliable resource for further reading.

Common Questions About GDM Screening

Can I eat or drink before the glucose challenge test?

For the 50-gram GCT (two-step initial test), you do not need to fast. However, it is advisable to avoid sugary foods or drinks in the hours before, as they may artificially inflate your result. For the OGTT (either one-step or two-step diagnostic), you must fast for at least 8 hours beforehand. Only water is allowed.

What if I vomit after drinking the glucose solution?

Nausea is a common side effect, especially in the second trimester. If vomiting occurs within the first hour of the OGTT, the test may need to be rescheduled. Your provider can discuss strategies to reduce nausea, such as drinking the solution slowly and chilling it beforehand.

Do I need to repeat the test if I had it in a previous pregnancy?

Yes. GDM typically resolves after delivery but can recur in subsequent pregnancies. Each pregnancy should be screened independently. If you had GDM before, you are at higher risk and may be offered early screening.

Can I opt out of screening if I have no risk factors?

While screening is recommended for all pregnant women, the decision is ultimately yours. Discuss any concerns with your provider. Keep in mind that 40-50% of women diagnosed with GDM have no obvious risk factors, making universal screening valuable.

Final Thoughts

The best time to schedule your GDM screening test is typically between 24 and 28 weeks of pregnancy. If you have risk factors, earlier screening may be appropriate, but a repeat test near the standard window is still advised. No matter your circumstances, open communication with your healthcare provider ensures that the timing of your screening is personalized to your health history and pregnancy progress. Early, accurate detection of gestational diabetes paves the way for simple but effective interventions that protect both you and your baby — now and in the years to come.

For more authoritative information on gestational diabetes and pregnancy, visit the CDC Gestational Diabetes page, and the NIDDK Gestational Diabetes Overview.